Comparative excretion and tissue distribution of selenium in mice and rats following treatment with diphenyl diselenide.
The purpose of this study was to provide data about in vivo tissue distribution and excretion of diphenyl diselenide ((PhSe)₂) in rats and mice through determination of selenium levels in different biological samples. (PhSe)₂ (500 mg/kg, dissolved in canola oil) was administered to animals once a day per oral. After this, mice and rats were housed in metabolic cages (one animal per cage) and urine and feces were collected at specific times after treatment. Three to five animals per group (for each time-point) were anesthetized and blood samples were collected at 0 and 30 min, 24 h, at day 5, 15, and 30 after (PhSe)₂ administration. The plasma and red blood cells were separated. Brain, liver, lungs, kidneys, and adipose tissue were also collected. The determination of selenium levels was performed by inductively coupled plasma atomic emission spectrometry. The main results indicate that: (1) urine is an important route of excretion of selenium originated from (PhSe)₂ in mice and rats; (2) a large amount of (PhSe)₂ or some of its metabolites are stored in fat; (3) the content of selenium found in plasma was low; and (4) liver and kidneys are the tissues with high amounts of selenium.
Universidade Federal do Pampa (UNIPAMPA), Campus Itaqui, CEP 97.650-000, Itaqui, RS, Brazil. marinaprigol@gmail.com
Marina
M
Prigol
César Augusto
CA
Brüning
Franciele
F
Martini
Cristina W
CW
Nogueira
D000273:Adipose Tissue / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D001555:Benzene Derivatives / Q000009:adverse effects / Q000032:analysis / Q000378:metabolism / Q000493:pharmacokinetics*; D001711:Biotransformation; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D004912:Erythrocytes / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism; D005243:Feces / Q000737:chemistry; D007668:Kidney / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D008099:Liver / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D008168:Lung / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism; D008297:Male; D008657:Metabolic Clearance Rate; D051379:Mice; D009474:Neurons / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism; D016566:Organoselenium Compounds / Q000009:adverse effects / Q000032:analysis / Q000378:metabolism / Q000493:pharmacokinetics*; D051381:Rats; D017208:Rats, Wistar; D012643:Selenium / Q000032:analysis / Q000097:blood / Q000378:metabolism* / Q000652:urine; D013045:Species Specificity; D013054:Spectrophotometry, Atomic; D014018:Tissue Distribution
D001555:Benzene Derivatives; D016566:Organoselenium Compounds; C061132:diphenyldiselenide; D012643:Selenium